LON:ABCAbcam Share Price, Forecast & News

Abcam's stock was trading at GBX 1,140 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ABC shares have increased by 18.0% and is now trading at GBX 1,345. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Abcam.

Abcam declared a dividend on Monday, March 9th. Stockholders of record on Thursday, March 19th will be given a dividend of GBX 3.55 per share on Friday, April 17th. This represents a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, March 19th. The official announcement can be seen at this link. View Abcam's dividend history.

6 equities research analysts have issued twelve-month price targets for Abcam's stock. Their forecasts range from GBX 1,220 to GBX 1,450. On average, they expect Abcam's share price to reach GBX 1,346 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price. View analysts' price targets for Abcam.

Headlines about ABC stock have been trending neutral recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Abcam earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Abcam.

Some companies that are related to Abcam include Vir Biotechnology (VIR), MorphoSys (MOR), MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (MOR), MorphoSys (MOR), BTG (BTG), Cronos Group (CRON), Kodiak Sciences (KOD), Genus (GNS), Viela Bio (VIE), Mesoblast (MSB), Polynovo (PNV), NGM Biopharmaceuticals (NGM), Concordia International (CXR), Clinuvel Pharmaceuticals (CUV) and BELLUS Health (BLU). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), HSBC (HSBA), Centrica (CNA) and Marks and Spencer Group (MKS).

Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."

Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of ABC stock can currently be purchased for approximately GBX 1,345.

Abcam has a market capitalization of £2.91 billion and generates £273.40 million in revenue each year. Abcam employs 1,100 workers across the globe.

The official website for Abcam is www.abcam.com.

Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.